Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid Leukemia
- Conditions
- Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
- Registration Number
- KCT0004825
- Lead Sponsor
- Chonnam National University Hospital Hwasun Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 620
Patients with newly diagnosed with acute myeloid leukemia by 4th edition of WHO criteria
19 years of age or greater
Patients will receive intensive induction therapy
Female patients of childbearing potential must have negative pregnancy test results at entry.
Ability to understand the study objectives and willingness to sign written consent
Have other active malignancy
Pregnant of lactating women
Patients who have no desire to participate in the study
Isolated extramedullary myeloid sarcoma
Diagnosed with acute promyelocytic leukemia (APL) (FAB classification: M3).
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival;Relapse-free survival;treatment related mortality
- Secondary Outcome Measures
Name Time Method cumulative incidence of relapse
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.